Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	Dizziness	Nervous system disorders	Tolvaptan 3.75 mg	0	10
other	Dizziness	Nervous system disorders	Tolvaptan 7.5 mg	1	10
other	Dizziness	Nervous system disorders	Tolvaptan 15 mg	1	9
other	Insomnia	Psychiatric disorders	Tolvaptan 3.75 mg	0	10
other	Insomnia	Psychiatric disorders	Tolvaptan 7.5 mg	0	10
other	Insomnia	Psychiatric disorders	Tolvaptan 15 mg	1	9
other	Polyuria	Renal and urinary disorders	Tolvaptan 3.75 mg	0	10
other	Polyuria	Renal and urinary disorders	Tolvaptan 7.5 mg	0	10
other	Polyuria	Renal and urinary disorders	Tolvaptan 15 mg	1	9
serious	Small cell lung cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Tolvaptan 3.75 mg	0	10
serious	Small cell lung cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Tolvaptan 7.5 mg	0	10
serious	Small cell lung cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Tolvaptan 15 mg	1	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02009878/events